조류 인플루엔자 치료제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global avian flu treatment market size is expected to reach USD 45.43 Billion in 2034 from USD 19.39 Billion in 2025, growing at a CAGR of 9.92 during 2026-2034.This market is experiencing steady growth due to increasing concerns regarding outbreaks of avian influenza and their impact on public health and poultry industries. The demand for effective antiviral drugs, vaccines, and supportive treatment solutions has increased as governments and healthcare organizations strengthen disease preparedness programs. Rising surveillance efforts and growing awareness of zoonotic disease transmission are supporting market expansion. Investments in infectious disease research and rapid response infrastructure are further contributing to market development.

The market is being driven by advancements in antiviral therapies, vaccine development, and diagnostic technologies that enable earlier detection and treatment of infections. Healthcare authorities are prioritizing stockpiling strategies and pandemic preparedness initiatives to mitigate the risks associated with avian influenza outbreaks. Increased collaboration among pharmaceutical companies, research institutions, and public health agencies is accelerating innovation. Additionally, growing concerns about emerging viral strains are encouraging continued investment in treatment development.

Future prospects remain favorable as governments and healthcare systems focus on strengthening infectious disease management capabilities. Advances in biotechnology and immunology are expected to improve treatment effectiveness and broaden preventive options. Increasing global emphasis on disease surveillance and rapid outbreak containment will support long-term market demand. As concerns regarding pandemic preparedness continue to grow, the avian flu treatment market is expected to witness sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Antibiotics
• Vaccines
• Antiviral Agents
• Immunoglobulins

By Distribution Channel

• Online Pharmacies
• Offline Pharmacies

By End User

• Hospital
• Institutional Health Centers
• Clinics

COMPANIES PROFILED

• GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Pfizer Inc., Sanofi S.A., Novartis AG, Gilead Sciences Inc., BioCryst Pharmaceuticals Inc., Cipla Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Novavax Inc., CSL Limited, Moderna Inc., Inovio Pharmaceuticals Inc., CureVac AG

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AVIAN FLU TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Antiviral Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Immunoglobulins Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AVIAN FLU TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Offline Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AVIAN FLU TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Institutional Health Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AVIAN FLU TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Distribution Channel
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Distribution Channel
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Distribution Channel
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Distribution Channel
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Distribution Channel
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL AVIAN FLU TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 GlaxoSmithKline Plc
  • 9.2.2 F. Hoffmann-La Roche Ltd
  • 9.2.3 Pfizer Inc
  • 9.2.4 Sanofi S.A
  • 9.2.5 Novartis AG
  • 9.2.6 Gilead Sciences Inc
  • 9.2.7 BioCryst Pharmaceuticals Inc
  • 9.2.8 Cipla Ltd
  • 9.2.9 Sinovac Biotech Ltd
  • 9.2.10 Emergent BioSolutions Inc
  • 9.2.11 Novavax Inc
  • 9.2.12 CSL Limited
  • 9.2.13 Moderna Inc
  • 9.2.14 Inovio Pharmaceuticals Inc
  • 9.2.15 CureVac AG